SomnoMed posts record Q4 and delivers on FY22 revenue guidance
Dental News and Technology
JULY 28, 2022
On an underlying basis, when excluding the Q4 FY21 COVID-19 related HIC 1 allowance, Q4 FY22 revenue was up +36% (+37% in constant currency) versus pcp Full year unaudited revenue of $72.6 million, up +16% (+17% in constant currency) versus pcp and above guidance of +15% growth for FY22. million for the quarter (positive $1.8
Let's personalize your content